Académique Documents
Professionnel Documents
Culture Documents
Drug classes
Antihypertensive
Angiotensin-converting enzyme (ACE) inhibitor
Therapeutic actions
Blocks ACE from converting angiotensin I to angiotensin II, a potent vasoconstrictor,
leading to decreased BP, decreased aldosterone secretion, a small increase in serum
potassium levels, and sodium and fluid loss; increased prostaglandin synthesis also may
be involved in the antihypertensive action.
Indications
• Treatment of hypertension alone or in combination with thiazide-type diuretics
Available forms
Tablets—5, 10, 20, 40 mg
Dosages
ADULTS
Initial dose, 10 mg PO daily. Maintenance dose, 20–40 mg/day PO, single or two divided
doses. Patients using diuretics should discontinue them 2–3 d prior to benazepril therapy.
If BP is not controlled, add diuretic slowly. If diuretic cannot be discontinued, begin
benazepril therapy with 5 mg. Maximum dose, 80 mg.
PEDIATRIC PATIENTS
Safety and efficacy not established.
PATIENTS WITH RENAL IMPAIRMENT
For creatinine clearance < 30 mL/min/1.73 m2 (serum creatinine > 3 mg/dL), 5 mg PO
daily. Dosage may be gradually increased until blood pressure is controlled, up to a
maximum of 40 mg/day.
Pharmacokinetics
Route Onset Peak Duration
Oral 0.5–1 hr 3–4 hr 24 hr
Adverse effects
• CV: Angina pectoris, hypotension in salt- or volume-depleted patients,
palpitations
• Dermatologic: Rash, pruritus, diaphoresis, flushing
• GI: Nausea, abdominal pain, vomiting, constipation
• Respiratory: Cough, asthma, bronchitis, dyspnea, sinusitis
• Other: Angioedema, impotence, decreased libido, asthenia, myalgia, arthralgia
Interactions
Drug-drug
• Increased risk of hypersensitivity reactions with allopurinal
• Increased coughing with capsaicin
• Decreased antihypertensive effects with indomethacin and other NSAIDs
• Increased lithium levels and neurotoxicity may occur if combined
• Increased risk of hyperkalemia with potassium-sparing diuretics or potassium
supplements
Nursing considerations
Assessment
• History: Allergy to benazepril or other ACE inhibitors, impaired renal function,
CHF, salt or volume depletion, lactation, pregnancy
• Physical: Skin color, lesions, turgor; T; P, BP, peripheral perfusion; mucous
membranes, bowel sounds, liver evaluation; urinalysis, renal and liver function
tests, CBC and differential
Interventions
• Alert surgeon: Note use of benazepril on patient's chart; the angiotensin II
formation subsequent to compensatory renin release during surgery will be
blocked; hypotension may be reversed with volume expansion.
• Monitor patient for possible fall in BP secondary to reduction in fluid volume
(excessive perspiration and dehydration, vomiting, diarrhea) because excessive
hypotension may occur.
• Reduce dosage in patients with impaired renal function.
Teaching points
• Do not stop taking the medication without consulting your health care provider.
• Be careful in any situation that may lead to a drop in blood pressure (diarrhea,
sweating, vomiting, dehydration); if light-headedness or dizziness occurs, consult
your health care provider.
• These side effects may occur: GI upset, loss of appetite (transient effects; if
persistent consult health care provider); light-headedness (transient; change
position slowly, and limit activities to those that do not require alertness and
precision); dry cough (irritating but not harmful; consult health care provider).
• Report mouth sores; sore throat, fever, chills; swelling of the hands, feet; irregular
heartbeat, chest pains; swelling of the face, eyes, lips, tongue, difficulty breathing,
persistent cough.
Adverse effects in Italic are most common; those in Bold are life-threatening.